Reneo Pharmaceuticals, Inc. (RPHM) Financials
RPHM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 130.4 million | 15.4 million |
2023-06-30 | 148.0 million | 15.5 million |
2023-03-31 | 98.9 million | 11.8 million |
2022-12-31 | 108.2 million | 8.2 million |
RPHM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -18.8 million | 1.4 million |
2023-06-30 | -16.1 million | 1.2 million |
2023-03-31 | -9.2 million | 1.2 million |
2022-12-31 | -15.9 million | 1.2 million |
RPHM Net Income
No data available :(
RPHM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 125.6 million | - | 1.1 million |
2023-06-30 | 142.7 million | - | 1.2 million |
2023-03-31 | 93.8 million | - | 1.3 million |
2022-12-31 | 101.2 million | - | 1.5 million |
RPHM Shares Outstanding
RPHM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 19000 | 13.6 million | 7.3 million | - |
2023-06-30 | 5000 | 14.4 million | 6.6 million | - |
2023-03-31 | 172000 | 11.0 million | 5.1 million | - |
2022-12-31 | 250000 | 10.4 million | 4.2 million | - |
RPHM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 43000 |
2023-06-30 | - | 163000 |
2023-03-31 | - | 161000 |
2022-12-31 | - | 128000 |
RPHM
Price: $1.73
52 week price:
Earnings Per Share: -2.52 USD
P/E Ratio: -0.74
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 37300
Market Capitalization: 56.1 million